CANY
FMTX

Caxton Associates (New York)’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Caxton Associates (New York)’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,190
Closed -$682K – 653
2022
Q3 		$682K Sell
34,190
-170,404
-83% -$2.25M 0.09% 178
2022
Q2 		$1.41M Buy
+204,594
New +$1.44M 0.14% 68

Caxton Associates (New York)'s FMTX Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 34,190 shares — an estimated $682K sold.

Caxton Associates (New York) first reported a position in FMTX in Q2 2022 and held it in 2 quarters. The position peaked at $1.41M in Q2 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 34,190 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $682K.
  • Caxton Associates (New York) first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Caxton Associates (New York)'s Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.41M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.